
Among our top 10 stories this week: A study has found the Pfizer COVID-19 vaccine to have a significantly reduced …

A number of new COVID-19 developments have emerged in April already: AstraZeneca has halted the trial of its COVID-19 vaccine …

In the last week, a number of new COVID-19 developments have emerged; Novavax has delayed 100 million vaccines to the …

In the last week, a number of new developments have made the news; for COVID-19, Starpharma will begin to sell …

In the last week, a number of new developments have made the news; for COVID-19, the Oxford-AstraZeneca vaccine has been …

In the last week, a number of new treatment developments have made the news; for COVID-19, GSK and Vir’s monoclonal-antibody …

COVID-19 news has slowed down in the last week, allowing different pharma developments to take centre stage. In the last …

The top ten news stories this week focus on clinical trial data, as Amgen and Novartis have revealed new five-year …

This week has been an interesting one for pharmaceutical innovation. A number of stories and studies have arisen about trialling …

This week has seen the pharmaceutical industry return to business as usual after the presidential election provided a boost to …

This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …

This week has seen pharmaceutical companies release their third quarter profits, good news for some whilst others have attempted to …

The latest issue of Pharmafocus is now live and ready to be read! We’ve taken the opportunity to cover some of …

This week has seen a few big collaboration and partnerships occur, whilst there have been some major movements within immunotherapy …

This week has seen a lot of news regarding specific drugs going through trial and some impressive results within. Read …